Home / CHF / NextImmune wins CHF 150,000 to develop a new generation of immunosuppressive drugs

NextImmune wins CHF 150,000 to develop a new generation of immunosuppressive drugs

NextImmune has identified a novel class of small molecules that suppress unwanted autoimmune responses and transplant rejection responses while maintaining the immune responses needed to defend …
Read Full Story at source (may require registration)